Armata Pharmaceuticals (ARMP) Treasury Shares (2018 - 2026)
Quarterly results put Treasury Shares at $135000.0 for Q1 2026, down 33.33% from a year ago — trailing twelve months through Mar 2026 was $135000.0 (down 33.33% YoY), and the annual figure for FY2025 was $152500.0, down 30.68%.
Armata Pharmaceuticals has reported Treasury Shares over the past 9 years, most recently at $135000.0 for Q1 2026.
- Treasury Shares reached $135000.0 in Q1 2026 per ARMP's latest filing, down from $152500.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $290000.0 in Q1 2024 and bottomed at $9748.0 in Q2 2023.
- Median Treasury Shares over the past 5 years was $152500.0 (2025), compared with a mean of $158374.6.
- The largest annual shift saw Treasury Shares tumbled 92.48% in 2023 before it soared 2874.97% in 2024.
- Over 5 years, Treasury Shares stood at $30000.0 in 2022, then soared by 566.67% to $200000.0 in 2023, then grew by 10.0% to $220000.0 in 2024, then crashed by 30.68% to $152500.0 in 2025, then dropped by 11.48% to $135000.0 in 2026.
- Business Quant data shows Treasury Shares for ARMP at $135000.0 in Q1 2026, $152500.0 in Q4 2025, and $152500.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 700,000.00 |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 34.70 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | Armata Pharmaceuticals | 301.92 Mn | 297.17 Mn | - | 135,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 135,000.00 |
| Mar 31, 2026 | 135,000.00 |
| Dec 31, 2025 | 152,500.00 |
| Dec 31, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Sep 30, 2025 | 152,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Jun 30, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Mar 31, 2025 | 202,500.00 |
| Dec 31, 2024 | 220,000.00 |
| Dec 31, 2024 | 220,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Jun 30, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Mar 31, 2024 | 290,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Dec 31, 2023 | 200,000.00 |
| Sep 30, 2023 | 34,851.00 |
| Sep 30, 2023 | 34,851.00 |
| Jun 30, 2023 | 9,748.00 |
| Jun 30, 2023 | 9,748.00 |
| Mar 31, 2023 | 129,666.00 |
| Mar 31, 2023 | 129,666.00 |
| Dec 31, 2022 | 30,000.00 |
| Dec 31, 2022 | 30,000.00 |
| Sep 30, 2022 | 129,666.00 |
| Sep 30, 2022 | 129,666.00 |
| Jun 30, 2022 | 129,666.00 |
| Jun 30, 2022 | 129,666.00 |
| Mar 31, 2022 | 153,772.00 |
| Mar 31, 2022 | 153,772.00 |
| Dec 31, 2021 | 154,018.00 |
| Dec 31, 2021 | 154,018.00 |
| Sep 30, 2021 | 154,018.00 |
| Sep 30, 2021 | 154,018.00 |
| Jun 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 30,000.00 |
| Mar 31, 2021 | 70,000.00 |
| Mar 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 322,756.00 |
| Dec 31, 2020 | 322,756.00 |
| Sep 30, 2020 | 262,558.00 |
| Sep 30, 2020 | 262,558.00 |
| Jun 30, 2020 | 262,558.00 |
| Jun 30, 2020 | 262,558.00 |
| Mar 31, 2020 | 340,164.00 |
| Mar 31, 2020 | 340,164.00 |
| Dec 31, 2019 | 343,493.00 |
| Dec 31, 2019 | 343,493.00 |
| Sep 30, 2019 | 355,034.00 |
| Sep 30, 2019 | 355,034.00 |
| Jun 30, 2019 | 408,389.00 |
| Jun 30, 2019 | 408,389.00 |
| Dec 31, 2018 | 416,856.00 |
| Dec 31, 2018 | 416,856.00 |